Your browser doesn't support javascript.
loading
Incoming HIV virion-derived Gag Spacer Peptide 2 (p1) is a target of effective CD8+ T cell antiviral responses.
Yang, Hongbing; Llano, Anuska; Cedeño, Samandhy; von Delft, Annette; Corcuera, Angelica; Gillespie, Geraldine M; Knox, Andrew; Leneghan, Darren B; Frater, John; Stöhr, Wolfgang; Fidler, Sarah; Mothe, Beatriz; Mak, Johnson; Brander, Christian; Ternette, Nicola; Dorrell, Lucy.
Afiliación
  • Yang H; Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK; National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford, Oxford OX4 2PG, UK; Research In Viral Eradication of Reservoirs (RIVER) trial study group. Electronic address: hongbing.yang@ndm.
  • Llano A; Irsicaixa AIDS Research Institute-HIVACAT, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain.
  • Cedeño S; Irsicaixa AIDS Research Institute-HIVACAT, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain.
  • von Delft A; National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford, Oxford OX4 2PG, UK; Centre for Medicines Discovery, University of Oxford, Oxford, UK.
  • Corcuera A; Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK.
  • Gillespie GM; Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK.
  • Knox A; Immunocore Ltd, Milton, Abingdon OX14 4RY, UK.
  • Leneghan DB; Immunocore Ltd, Milton, Abingdon OX14 4RY, UK.
  • Frater J; Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK; National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford, Oxford OX4 2PG, UK; Research In Viral Eradication of Reservoirs (RIVER) trial study group.
  • Stöhr W; Medical Research Council Clinical Trials Unit, University College London, London WC1V 6LJ, UK; Research In Viral Eradication of Reservoirs (RIVER) trial study group.
  • Fidler S; Department of Infectious Disease, Imperial College London, National Institute for Health Research Imperial Biomedical Research Centre, London W2 1NY, UK; Research In Viral Eradication of Reservoirs (RIVER) trial study group.
  • Mothe B; Irsicaixa AIDS Research Institute-HIVACAT, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain; Faculty of Medicine, Universitat de Vic-Central de Catalunya (UVic-UCC), 08500 Vic, Spain; Fundació Lluita contra la Sida, Infectious Disease Department, Hospital Universitari Germans Trias
  • Mak J; Institute for Glycomics, Griffith University Gold Coast, Southport QLD 4215, Australia.
  • Brander C; Irsicaixa AIDS Research Institute-HIVACAT, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain; Faculty of Medicine, Universitat de Vic-Central de Catalunya (UVic-UCC), 08500 Vic, Spain; Institució Catalana de Recerca I Estudis Avançats (ICREA), 08010 Barcelona, Spain.
  • Ternette N; Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK.
  • Dorrell L; Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK; National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford, Oxford OX4 2PG, UK; Immunocore Ltd, Milton, Abingdon OX14 4RY, UK; Research In Viral Eradication of Reservoirs (RIVER) trial stud
Cell Rep ; 35(6): 109103, 2021 05 11.
Article en En | MEDLINE | ID: mdl-33979627
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Antivirales / Péptidos / Virión / Infecciones por VIH / Linfocitos T CD8-positivos Límite: Humans Idioma: En Revista: Cell Rep Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Antivirales / Péptidos / Virión / Infecciones por VIH / Linfocitos T CD8-positivos Límite: Humans Idioma: En Revista: Cell Rep Año: 2021 Tipo del documento: Article